1. Home
  2. Stock quotes
  3. AxoGen
  4. Financial Statements
  5. Balance Sheet
AxoGen logo
AxoGen AXGN
$ 29.44 -1.31%

Annual report 2025
added 02-24-2026

report update icon

AxoGen Balance Sheet 2011-2026 | AXGN

Annual Balance Sheet AxoGen

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

 15.2 M 21.9 M 11.1 M 25.5 M 7.64 M -22.7 M -32.4 M -24.2 M -11.9 M -5.7 M -362 K 16.9 M 5.29 M 7.67 M -3.35 M

Long Term Debt

 48.4 M 47.5 M 46.6 M 45.7 M 44.8 M 32 M 1.6 M 35 K 19.9 M 20.3 M 25.5 M 25.1 M 25.4 M 21.6 M 4.4 M

Long Term Debt Current

 2.35 M 1.96 M 1.54 M 1.3 M 1.82 M 846 K 1.72 M 28 K 735 K 20.9 K - - - - 435 K

Total Non Current Liabilities

 - - - - - - 1.61 M 147 K 20 M 20.4 M 25.6 M 25.2 M 25.4 M 21.6 M 4.4 M

Total Current Liabilities

 23.6 M 30.6 M 30.4 M 23.8 M 24.3 M 22.8 M 20.9 M 13 M 13.7 M 11.1 M 3.71 M 2.45 M 2.1 M 1.48 M 2.02 M

Total Liabilities

 92.8 M 99.8 M 101 M 94.4 M 95.5 M 78.2 M 22.5 M 13.2 M 33.7 M 31.4 M 29.4 M 27.6 M 27.5 M 23.1 M 6.42 M

Deferred Revenue

 - - - - - - 14 K 18 K 31.7 K 33.3 K 14.1 K 14.1 K 14.1 K - -

Retained Earnings

 -307 M -291 M -281 M -260 M -231 M -204 M -180 M -151 M -128 M -118 M -103 M -90.1 M -72.4 M -57.8 M -48.4 M

Total Assets

 222 M 204 M 197 M 195 M 208 M 201 M 155 M 160 M 58.9 M 46.4 M 37.5 M 16.4 M 27.7 M 20.2 M 12.5 M

Cash and Cash Equivalents

 35.5 M 27.6 M 37 M 21.5 M 39 M 55.6 M 35.7 M 24.3 M 36.5 M 30 M 25.9 M 8.22 M 20.1 M 13.9 M 8.19 M

Book Value

 129 M 104 M 95.7 M 101 M 113 M 123 M 132 M 147 M 25.2 M 14.9 M 8.2 M -11.2 M 137 K -2.83 M 6.07 M

Total Shareholders Equity

 129 M 104 M 95.7 M 101 M 113 M 123 M 132 M 147 M 25.2 M 14.9 M 8.2 M -11.2 M 137 K -2.83 M 6.07 M

All numbers in USD currency

Quarterly Balance Sheet AxoGen

2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

 47.9 M 47.7 M 47.5 M 47.3 M 47 M 46.8 M 46.6 M 46.4 M 46.2 M 45.9 M 45.7 M 45.5 M - 45 M 44.8 M 46.2 M 46.1 M 32.1 M 32 M 32 M 32 M 32 M - 1.6 M 2.38 M 1.6 M 35 K 35 K 35 K 35 K 19.8 M 19.8 M 19.8 M 19.8 M 20.3 M 20.3 M 20.3 M 20.3 M 24.7 M - - - 25.1 M 28.2 M 27.2 M 26.3 M 25.4 M 25.4 M 25.4 M 25.4 M 21.6 M 21.6 M 21.6 M 21.6 M 4.4 M 4.4 M 4.4 M 4.4 M

Total Liabilities

 93.2 M 90.8 M 99.8 M 92.6 M 93.2 M 93.4 M 101 M 96.8 M 94.5 M 92 M 94.4 M 94.1 M - 94.2 M 95.5 M 94.7 M 91.8 M 77.7 M 78.2 M 78.2 M 78.2 M 78.2 M 22.5 M 22.5 M 22.5 M 22.5 M 13.2 M 13.2 M 13.2 M 13.2 M 33.7 M 33.7 M 33.7 M 33.7 M 31.4 M 31.4 M 31.4 M 31.4 M 28.5 M 28.5 M 28.5 M 28.5 M 27.6 M 27.6 M 27.6 M 27.6 M 27.5 M 27.5 M 27.5 M 27.5 M 23.1 M 23.1 M 23.1 M 23.1 M 6.42 M 6.42 M 6.42 M 6.42 M

Deferred Revenue

 - - - - - - - - - - - - - - 14 K 14 K 14 K 14 K 14 K 14 K 14 K 14 K 14 K 14 K 14 K 14 K 18 K 18 K 18 K 18 K 31.7 K 43.6 K 39.4 K 35.2 K 33.3 K 33.3 K 33.3 K 33.3 K 14.1 K 14.1 K 14.1 K 14.1 K 14.1 K 14.1 K 14.1 K 14.1 K 14.1 K 14.1 K 14.1 K 14.1 K - - - - - - - -

Retained Earnings

 -295 M -295 M -291 M -292 M -290 M -288 M -281 M -277 M -273 M -267 M -260 M -254 M - -242 M -231 M -225 M -218 M -210 M -204 M -204 M -204 M -204 M -180 M -180 M -180 M -180 M -151 M -151 M -151 M -151 M -128 M -128 M -128 M -128 M -118 M -118 M -118 M -118 M -103 M -103 M -103 M -103 M -90.1 M -90.1 M -90.1 M -90.1 M -72.4 M -72.4 M -72.4 M -72.4 M -57.8 M -57.8 M -57.8 M -57.8 M -48.4 M -48.4 M -48.4 M -48.4 M

Total Assets

 205 M 196 M 204 M 192 M 189 M 187 M 197 M 195 M 192 M 189 M 195 M 196 M - 198 M 208 M 210 M 211 M 197 M 201 M 201 M 201 M 201 M 155 M 155 M 155 M 155 M 160 M 160 M 160 M 160 M 58.9 M 58.9 M 58.9 M 58.9 M 46.4 M 46.4 M 46.4 M 46.4 M 36.7 M 36.7 M 36.7 M 36.7 M 16.4 M 16.4 M 16.4 M 16.4 M 27.7 M 27.7 M 27.7 M 27.7 M 20.2 M 20.2 M 20.2 M 20.2 M 12.5 M 12.5 M 12.5 M 12.5 M

Cash and Cash Equivalents

 20 M 18.1 M 27.6 M 18.7 M 25.2 M 21.7 M 31 M 37.1 M 29.5 M 14 M 15.3 M 20.6 M 18.1 M 20.8 M 32.8 M 53.1 M 53.1 M 39.8 M 48.8 M 48.8 M 48.8 M 48.8 M 35.7 M 35.7 M 35.7 M 35.7 M 24.3 M 24.3 M 24.3 M 24.3 M 36.5 M 36.5 M 36.5 M 36.5 M 30 M 30 M 30 M 30 M 25.9 M 25.9 M 25.9 M 25.9 M 8.22 M 8.22 M 8.22 M 8.22 M 20.1 M 20.1 M 20.1 M 20.1 M 13.9 M 13.9 M 13.9 M 13.9 M 8.19 M 8.19 M 8.19 M 8.19 M

Book Value

 112 M 105 M 104 M 99.4 M 95.7 M 93.2 M 95.7 M 97.8 M 97.2 M 97.5 M 101 M 101 M - 104 M 113 M 115 M 119 M 120 M 123 M 123 M 123 M 123 M 132 M 132 M 132 M 132 M 147 M 147 M 147 M 147 M 25.2 M 25.2 M 25.2 M 25.2 M 14.9 M 14.9 M 14.9 M 14.9 M 8.2 M 8.2 M 8.2 M 8.2 M -11.2 M -11.2 M -11.2 M -11.2 M 137 K 137 K 137 K 137 K -2.83 M -2.83 M -2.83 M -2.83 M 6.07 M 6.07 M 6.07 M 6.07 M

Total Shareholders Equity

 112 M 105 M 104 M 99.4 M 95.7 M 93.2 M 95.7 M 97.8 M 97.2 M 97.5 M 101 M 101 M 102 M 104 M 113 M 115 M 119 M 120 M 123 M 123 M 123 M 123 M 132 M 132 M 132 M 132 M 147 M 147 M 147 M 147 M 25.2 M 25.2 M 25.2 M 25.2 M 14.9 M 14.9 M 14.9 M 14.9 M 8.2 M 8.2 M 8.2 M 8.2 M -11.2 M -11.2 M -11.2 M -11.2 M 137 K 137 K 137 K 137 K -2.83 M -2.83 M -2.83 M -2.83 M 6.07 M 6.07 M 6.07 M 6.07 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of AxoGen, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Aziyo Biologics Aziyo Biologics
AZYO
 		- 1.37 % $ 20.5 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
 		$ 38.77 -1.27 % $ 5.78 K usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
 		- - $ 1.77 B usaUSA
Conformis Conformis
CFMS
 		- - $ 16.4 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
 		- 24.59 % $ 44.8 M chinaChina
Cardiovascular Systems Cardiovascular Systems
CSII
 		- 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
 		- -10.19 % $ 1.99 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
 		- -5.86 % $ 30.6 M usaUSA
Acutus Medical Acutus Medical
AFIB
 		- -26.83 % $ 2.62 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
 		- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
 		- - $ 10.2 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
 		$ 8.09 3.45 % $ 581 M israelIsrael
Allied Healthcare Products Allied Healthcare Products
AHPI
 		- 3.58 % $ 2.21 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
 		- -0.97 % $ 54.4 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
 		$ 4.1 2.76 % $ 153 M franceFrance
Electromed Electromed
ELMD
 		$ 24.5 2.17 % $ 207 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
 		$ 9.69 3.09 % $ 1.31 B usaUSA
FONAR Corporation FONAR Corporation
FONR
 		$ 18.54 0.19 % $ 122 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
 		- - $ 475 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
 		$ 42.93 -1.11 % $ 1.33 B usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
 		- -4.14 % $ 702 M usaUSA
Avinger Avinger
AVGR
 		- -20.74 % $ 369 K usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
 		- 1.15 % $ 34.5 M usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
 		$ 3.26 2.84 % $ 113 M usaUSA
InMode Ltd. InMode Ltd.
INMD
 		$ 13.55 -0.37 % $ 876 M israelIsrael
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
 		- - $ 3.31 B usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
 		$ 105.35 1.02 % $ 1.33 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
 		- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
 		- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
 		- 0.03 % $ 1.58 B israelIsrael
Accuray Incorporated Accuray Incorporated
ARAY
 		$ 0.52 -0.36 % $ 53.4 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
 		- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
 		- - $ 111 M canadaCanada
LivaNova PLC LivaNova PLC
LIVN
 		$ 66.26 -3.17 % $ 3.61 B britainBritain
Medigus Ltd. Medigus Ltd.
MDGS
 		- 10.28 % $ 55.5 M israelIsrael
Pulmonx Corporation Pulmonx Corporation
LUNG
 		$ 1.47 -3.92 % $ 57.5 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
 		$ 0.79 -1.75 % $ 43 M usaUSA
Medtronic PLC Medtronic PLC
MDT
 		$ 96.0 -0.75 % $ 123 B usaUSA
Align Technology Align Technology
ALGN
 		$ 181.73 -0.5 % $ 13.6 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
 		- - $ 955 M usaUSA
Inari Medical Inari Medical
NARI
 		- - $ 4.23 B usaUSA
Butterfly Network Butterfly Network
BFLY
 		$ 3.97 7.88 % $ 840 M usaUSA
BIOLASE BIOLASE
BIOL
 		- -13.19 % $ 166 K usaUSA
Abbott Laboratories Abbott Laboratories
ABT
 		$ 113.65 0.04 % $ 198 B usaUSA
NuVasive NuVasive
NUVA
 		- - $ 2.07 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
 		- - $ 217 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
 		- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
 		$ 72.77 -1.46 % $ 108 B usaUSA
Orthofix Medical Orthofix Medical
OFIX
 		$ 12.98 -0.42 % $ 514 M curacaoCuracao